Zivo Bioscience (OTCMKTS:ZIVO) versus Danone (DANOY) Head-To-Head Analysis

Danone (OTCMKTS:DANOY) and Zivo Bioscience (OTCMKTS:ZIVO) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability and valuation.

Volatility & Risk

Danone has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Zivo Bioscience has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500.

Insider and Institutional Ownership

0.4% of Danone shares are held by institutional investors. Comparatively, 0.2% of Zivo Bioscience shares are held by institutional investors. 1.0% of Danone shares are held by insiders. Comparatively, 32.9% of Zivo Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Dividends

Danone pays an annual dividend of $0.41 per share and has a dividend yield of 2.6%. Zivo Bioscience does not pay a dividend. Danone pays out 48.8% of its earnings in the form of a dividend.

Profitability

This table compares Danone and Zivo Bioscience’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Danone N/A N/A N/A
Zivo Bioscience N/A N/A -1,396.66%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Danone and Zivo Bioscience, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danone 1 0 6 0 2.71
Zivo Bioscience 0 0 0 0 N/A

Earnings and Valuation

This table compares Danone and Zivo Bioscience’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Danone $29.11 billion 1.77 $2.78 billion $0.84 18.98
Zivo Bioscience N/A N/A -$14.63 million N/A N/A

Danone has higher revenue and earnings than Zivo Bioscience.

Summary

Danone beats Zivo Bioscience on 6 of the 9 factors compared between the two stocks.

About Danone

Danone SA operates in the food and beverage industry worldwide. The company operates through four segments: EDP International, EDP Noram, Specialized Nutrition, and Waters. It offers yogurts under the DanActive, Danimals, Dannon, Danonino, Light & Fit, Oikos, Wallaby, YoCrunch, Danone, Danonino or Prostokvashino, Light & Free, and Vitalinea brand names; and almond-based, cashew-based, soy-based products, ice creams and novelties, and nutrition products under the Silk, So Delicious, Vega, and Alpro brands. The company also provides coffee creamers and beverages under the International Delight and Dunkin brands; milk, cheese, and other organic dairy products under the Horizon brand; and packaged salads, green vegetables, as well as fresh and frozen organic fruits and vegetables under the Earthbound Farm brand. In addition, it offers specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Cow & Gate, Blédina, Bebelac, Malyutka, and Dumex brands. Further, the company provides oral and tube feeding products for the dietary treatment of babies and children; liquid oral nutritional supplements; and hypoallergenic products for babies and children with dairy or multiple food protein allergies primarily under the Nutricia brand. Additionally, it offers water with natural fruit juice extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, and Zywiec Zdroj brands. The company distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone SA in April 2009. Danone SA was founded in 1899 and is based in Paris, France.

About Zivo Bioscience

Zivo Bioscience, Inc., together with its subsidiaries, develops natural bioactive ingredients derived from its proprietary algal cultures. The company focuses on licensing and selling its natural bioactive ingredients to animal, human and dietary supplement, and medical food manufacturers; and license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that allow individuals to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to Zivo Bioscience, Inc. in November 2014. Zivo Bioscience, Inc. is headquartered in Keego Harbor, Michigan.

Receive News & Ratings for Danone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danone and related companies with MarketBeat.com's FREE daily email newsletter.